FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1639822038> ?p ?o ?g. }

• W1639822038 abstract "This study characterized a panel of NSCLC cell lines as well as a stably transfected cell model expressing wild-type and mutated EGFR variants in terms of response to the EGFR-targeting drugs, gefitinib and cetuximab. The examinations support the notion that response to gefitinib is neither exclusive nor strictly determined by the presence of EGFR kinase mutations. Yet, cells expressing EGFR kinase domain mutations tended to generally respond better to treatments with gefitinib compared to those with wild-type EGFR. On the other hand, preliminary studies suggesting that cellular sensitivity to cetuximab is determined by factors other than EGFR kinase domain mutations could be substantiated through a robust set of data. Moreover, several promising candidate genes differentially expressed in gefitinib sensitive and resistant NSCLC cell lines were revealed by a global mRNA expression analyses. In addition, though statistically questionable, several biologically interesting genes that are possibly involved in determining in vitro response of NSCLC cells to cetuximab have been postulated. In this work, four cancer cell models, which are long-term exposed to gefitinib or cetuximab were established and characterized in terms of gain-of-resistance towards EGFR-targeting compounds, as well as in regard to biological and molecular alterations caused by long-term treatments. It was found that gefitinib long-term treatment of primary sensitive A431 cells confered growth-resistance to this TKI, but not to cetuximab. This observation may have clinical implications for patients that relapsed on gefitinib as it suggests that they might still profit from cetuximab therapy. On the other hand long-term exposure of A431 cells to cetuximab did not render cells resistant to neither the antibody nor gefitinib in regard to in vitro growth-inhibition. Furthermore, it appeared that long-term gefitinib-treated A431 cells downregulate overall EGFR levels, while long-term cetuximab exposed cells displayed decreased EGFR surface levels but constant overall expression. In addition, a candidate-based approach identified genes that are differentially expressed in cancer cells with primary or secondary resistance to gefitinib or cetuximab. Finally, this study for the first time provided evidence that cetuximab may block metastasis-facilitating epithelial-mesenchymal-transition (EMT) in an epithelial cell line. Moreover, it was suggested that activation of the HGFR may compensate for cetuximab-mediated blockage of EGFR. This was also reflected by an increased response of this population towards treatment with HGFR inhibitors." @default.
• W1639822038 created "2016-06-24" @default.
• W1639822038 creator A5043627226 @default.
• W1639822038 date "2008-02-25" @default.
• W1639822038 modified "2023-09-27" @default.
• W1639822038 title "Molecular analyses of resistance and sensitivity mechanisms to anti-EGFR directed tumor therapy" @default.
• W1639822038 hasPublicationYear "2008" @default.
• W1639822038 type Work @default.
• W1639822038 sameAs 1639822038 @default.
• W1639822038 citedByCount "0" @default.
• W1639822038 crossrefType "dissertation" @default.
• W1639822038 hasAuthorship W1639822038A5043627226 @default.
• W1639822038 hasConcept C121608353 @default.
• W1639822038 hasConcept C126322002 @default.
• W1639822038 hasConcept C143998085 @default.
• W1639822038 hasConcept C184235292 @default.
• W1639822038 hasConcept C2777506169 @default.
• W1639822038 hasConcept C2779438470 @default.
• W1639822038 hasConcept C2779998722 @default.
• W1639822038 hasConcept C2780580887 @default.
• W1639822038 hasConcept C502942594 @default.
• W1639822038 hasConcept C526805850 @default.
• W1639822038 hasConcept C54009773 @default.
• W1639822038 hasConcept C54355233 @default.
• W1639822038 hasConcept C71924100 @default.
• W1639822038 hasConcept C81885089 @default.
• W1639822038 hasConcept C86803240 @default.
• W1639822038 hasConceptScore W1639822038C121608353 @default.
• W1639822038 hasConceptScore W1639822038C126322002 @default.
• W1639822038 hasConceptScore W1639822038C143998085 @default.
• W1639822038 hasConceptScore W1639822038C184235292 @default.
• W1639822038 hasConceptScore W1639822038C2777506169 @default.
• W1639822038 hasConceptScore W1639822038C2779438470 @default.
• W1639822038 hasConceptScore W1639822038C2779998722 @default.
• W1639822038 hasConceptScore W1639822038C2780580887 @default.
• W1639822038 hasConceptScore W1639822038C502942594 @default.
• W1639822038 hasConceptScore W1639822038C526805850 @default.
• W1639822038 hasConceptScore W1639822038C54009773 @default.
• W1639822038 hasConceptScore W1639822038C54355233 @default.
• W1639822038 hasConceptScore W1639822038C71924100 @default.
• W1639822038 hasConceptScore W1639822038C81885089 @default.
• W1639822038 hasConceptScore W1639822038C86803240 @default.
• W1639822038 hasLocation W16398220381 @default.
• W1639822038 hasOpenAccess W1639822038 @default.
• W1639822038 hasPrimaryLocation W16398220381 @default.
• W1639822038 hasRelatedWork W1561412036 @default.
• W1639822038 hasRelatedWork W1597915316 @default.
• W1639822038 hasRelatedWork W1971562198 @default.
• W1639822038 hasRelatedWork W1987321907 @default.
• W1639822038 hasRelatedWork W1998375723 @default.
• W1639822038 hasRelatedWork W2011026203 @default.
• W1639822038 hasRelatedWork W2019977765 @default.
• W1639822038 hasRelatedWork W2044312211 @default.
• W1639822038 hasRelatedWork W2083199051 @default.
• W1639822038 hasRelatedWork W2111955159 @default.
• W1639822038 hasRelatedWork W2114843158 @default.
• W1639822038 hasRelatedWork W2134669188 @default.
• W1639822038 hasRelatedWork W2266347788 @default.
• W1639822038 hasRelatedWork W2332684061 @default.
• W1639822038 hasRelatedWork W2552428494 @default.
• W1639822038 hasRelatedWork W2566896698 @default.
• W1639822038 hasRelatedWork W2619034493 @default.
• W1639822038 hasRelatedWork W2810406187 @default.
• W1639822038 hasRelatedWork W2908755091 @default.
• W1639822038 hasRelatedWork W3158267661 @default.
• W1639822038 isParatext "false" @default.
• W1639822038 isRetracted "false" @default.
• W1639822038 magId "1639822038" @default.
• W1639822038 workType "dissertation" @default.